通过炎症性 (fMLFII) 和亲溶解 (LXA4和RvD3) 激素激活ALX/FPR2受体
Vinicius S Nunes1, Charles N Serhan2, Odonírio Abrahão3
1Programa de Pós-Graduação em Produtos Bioativos e Biociências, Universidade Federal do Rio de Janeiro, Avenida Aluizio da Silva Gomes 50, Macaé 27930-560, Brasil.
ACS physical chemistry Au
|July 29, 2025
概括
调查ALX/FPR2受体激活,这项研究发现,残留物R201和R205对于亲解和亲炎症激动剂都是关键的,D106只与fMLFII.II相互作用.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- ALX/FPR2受体在炎症和解消途径中发挥作用.
- 之前的结构数据表明D106,R201和R205参与受体激活.
研究的目的:
- 通过计算模拟来研究ALX/FPR2受体激活机制.
- 为了比较促溶解激动剂 (LXA4,RvD3) 和促炎症激动剂 (fMLFII) 的作用.
主要方法:
- 采用了对接模拟和长期分子动力学模拟.
- 分析包括受体激活状态,静电相互作用和结合亲缘关系 (MM/PBSA).
主要成果:
- LXA4和fMLFII维持受体激活时间超过RvD3.
- 对于所有测试的激动剂,残留物R201和R205是关键的.
- fMLFII,但不是LXA4或RvD3,与残留物D106.3相互作用.
- 静电相互作用显著促进了激素主体与受体的结合.
结论:
- R201和R205对于各种激动剂的ALX/FPR2激活至关重要.
- D106在激活中的作用似乎是特定于某些激动剂,如fMLFII.
- 这项研究增强了对由亲解析和炎症分子激活ALX/FPR2的理解.
相关概念视频
Inflammatory Response
7.5K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
7.5K
Drug-Receptor Interaction: Agonist
2.8K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.8K
Analgesia and Pain Management
803
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
803
Opioid Receptors: Overview
1.8K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.8K
Adrenergic Receptors: ɑ Subtype
1.9K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.9K
The Two-State Receptor Model
2.4K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
2.4K


